KRAS and leiomyoma: Whereas mutations in MED12 are frequent in leiomyoma (~70%)18, recurrent mutations in cancer-associated genes such as KRAS, PIK3CA, ARID1A, PPP2R1A, PTEN, and/or TP53 occur in uterine endometrial carcinoma19.